1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Predictors of revascularization
TIMI 2–3 Flow P
No Yes
Demographics (patients) n = 4 n = 14 
    Age, years (mean ± SD) 67.5 ± 11.6 77.2 ± 10.8 .14
    Admission NIHSS (mean ± SD) 15.8 ± 5.2 16.4 ± 6.3 .86
    Time to angiography, minutes (mean ± SD) 372 ± 72 509 ± 894 .77
    Women (men) 0 (4) 10 (4) .02
Comorbidities (patients) n = 4 n = 14 
    Hypertension 4 13 .78
    Diabetes mellitus 1 2 .55
    Atrial fibrillation 2 5 .51
    Hyperlipidemia 3 5 .21
    Coronary artery disease 0 5 .23
Location (lesions) n = 4 n = 15 
    M1 MCA 0 4 .35
    M2 MCA 0 1 .79
    VBS 0 3 .47
    Any solitary lesion 0 8 .09
    M1 MCA + M2 MCA 0 4 .35
    ICA bifurcation + ICA terminus + M1 MCA 2 0 .04
    ICA bifurcation + M1 MCA 0 3 .47
    ICA terminus + M1 MCA 2 0 .04
    Limited to MCA (M1 or M2 MCA or M1+M2) 0 9 .05
    Limited to MCA or VBS 0 12 .01
Stent used (lesions) n = 4 n = 15 
    Neuroform 4 12 .47
    Wingspan 0 3 .47
Adjunctive treatment (lesions) n = 4 n = 15 
    IIb/IIIa inhibitor 3 7 .33
    IA thrombolysis 3 9 .53
    IV thrombolysis 2 3 .27
    Merci retriever 1 8 .33
    Angioplasty 1 9 .25
Clinical outcomes (patients) n = 4 n = 14 
    mRS score ≤ 3 0 6 .16
    mRS score ≤ 3 at 3 months 0 4 .42
    NIHSS score reduced by ≥ 4 0 7 .11
Note:—TIMI indicates Thrombolysis in Myocardial Infarction; NIHSS, National Institutes of Health Stroke Scale; MCA, middle cerebral artery; VBS, vertebrobasilar system; ICA, internal carotid artery; IA, intra-arterial; mRS, modified Rankin Scale.